Clemson University Research Foundation
Chris Gesswein, MT (ASCP), MS, MBA, is the Executive Director and Director of Licensing for Technology Transfer at the Clemson University Research Foundation (CURF) responsible for managing the day-to-day activities associated with commercializing Clemson University’s intellectual property portfolio. Prior to joining CURF, Chris served as the VP of Business Development at Ultradian Diagnostics, a clinical-stage biosensor medical device company developing a next generation continuous glucose monitoring system to help people with diabetes more effectively manage their disease. In this role, Chris was responsible for business strategy and planning, capital fund-raising, IP management, and FDA regulatory approval/compliance.
Chris has over 20 years of business experience bringing various technologies from concept to market working as a new product development and technology transfer specialist for early-stage as well as large multi-national companies.
Chris received a BA from West Virginia University, an MS in Biotechnology from Johns Hopkins University, and an MBA with concentrations in Entrepreneurship and Finance from Rensselaer Polytechnic Institute.